HIV/AIDS Clinical Preceptorship Program
for MDs, PAs, and NPs

This one or two day educational program is a clinic-based preceptorship for health care providers during which they will observe and work with an HIV expert preceptor. Preceptorships will be designed to meet the specific needs of individual trainees based on current levels of experience and practice settings. Preceptors will focus on the care and treatment of HIV+ patients within the context of a comprehensive, continuum of care model. A combination of didactic and experiential instruction will include HIV risk assessment, diagnosis of primary HIV and opportunistic infections, therapeutic interventions (i.e., drug treatment regimens including managing side effects, salvage therapies, and adherence strategies), and prevention with positives. Instruction will also include strategies for effectively addressing patients’ psychosocial needs related to mental health and substance abuse issues and social support. Participants (preceptees) will observe at least 4 HIV-infected patient work-ups under the guidance of the preceptor.

UW School of Medicine

The University of Washington, School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Washington, School of Medicine designates this live activity for a maximum of 16.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information about our preceptorship program contact Becky Karschney.

HIV Clinical Preceptorship Learning Objectives

Upon completion of this program, attendees should be able to:

  • Diagnose primary HIV infection
  • Conduct baseline evaluation of newly diagnosed HIV-infected patients
  • Cite principles underlying Antiretroviral Therapy (ART) initiation and maintenance
  • Recognize adverse and potentially life-threatening side effects of ART
  • Approach diagnosis/management of common HIV co-morbid conditions